E-mail: doubek.michael@fnbrno.cz
Odborné práce publikované na Linkos.cz
Přehled odborných textů publikovaných autorem na portálu Linkos.cz. Jsou zde uvedeny knihy a brožury, články v Klinické onkologii, tuzemská abstrakta z databáze abstrakt a další texty. Rejstřík není v žádném případě úplným autorským rejstříkem, protože jsou zde uvedeny pouze texty zveřejněné na portálu Linkos.cz.
Publikované knihy
Publikovaná abstrakta
- 13Q DELETION IS PREDOMINANT CYTOGENETIC ABERRATION NEWLY AQUIRED DURING CHRONIC LYMPHOCYTIC LEUKEMIA COURSE IRRESPECTIVE OF DISEASE ACTIVITY AND TREATMENT STATUS
- A Complementary Role of High Throughput Sequencing and Multiparameter Cytometry for Minimal Residual Disease (MRD) Detection in Chronic Lymphocytic Leukemia (CLL):an European Research Initiative (ERIC) Study
- A MULTICENTER, PHASE IV OBSERVATIONAL SAFETY STUDY OF OFATUMUMAB IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A EUROPEAN RESEARCH INITIATIVE ON CLL (ERIC) STUDY
- A Multicenter, Phase IV Observational Study Of Ofatumumab In Chronic Lymphocytic Leukemia (CLL): A European Research Initiative On CLL (ERIC) Study
- ACUTE LYMPHOBLASTIC LEUKEMIA IN THE ELDERLY: A TOUGH ONE
- ACUTE MYELOID LEUKEMIAS WITH RECURRENT GENETIC ABNORMALITIES: FREQUENT ASSESSMENT OF MINIMAL RESIDUAL DISEASE AND TREATMENT OF MOLECULAR RELAPSE
- Allogeneic Hematopoietic Cell Transplantation Is Effective In Patients With Advanced Systemic Mastocytosis: A Multicenter Retrospective Analysis
- ALLOGENEIC STEM CELL TRANSPLANTATIONS AFTER REDUCED INTENSITY CONDITIONING REGIMEN FLUDARABIN, BUSULFAN AND ATG (FRESENIUS)
- ANALYSIS OF 1458 ACUTE MYELOID LEUKEMIA FROM THE ALERT PROJECT (ACUTE LEUKEMIA CLINICAL REGISTER) IN THE CZECH REPUBLIC IN 1996-2006
- ANALYSIS OF MERKEL CELL POLYOMAVIRUS PROGNOSTIC SIGNIFICANCE IN CHRONIC LYMPHOCYTIC LEUKEMIA
- ANALYSIS OF POTENTIALLY BICLONAL CLL PATIENTS WITH TWO OR THREE PRODUCTIVE IGH REARRANGEMENTS
- ARE FLT3 ITD AND D835 MUTATIONS SUFFICIENT INDICATORS FOR ALLOGENEIC TRANSPLANTATION IN ACUTE MYELOID LEUKEMIA? AN ANALYSIS OF PATIENTS FROM THE CZECH ACUTE LEUKEMIA CLINICAL REGISTER (ALERT)
- ATM INACTIVATION DISTURBS ATM-P53 PATHWAY IN RESPONSE TO DNA DAMAGE INDUCED BY DOXORUBICIN BUT NOT FLUDARABINE IN CLL CELLS
- AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: STILL NOT OUT OF FASHION
- BIOLOGICAL AND CLINICAL RELEVANCE OF MIRNAS INDUCED IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) CELLS DURING ADMINISTRATION OF THERAPY IN VIVO AND IN VITRO
- Clinical Outcome of B-Cell Chronic Lymphocytic Leukemia Following Alemtuzumab Therapy: Retrospective Study within Various Cytogenetic Risk Categories
- Clonal Evolution and Therapy Related Selection Of TP53 Mutations In Chronic Lymphocytic Leukemia Patients
- Clonal Evolution of Malignant Populations In Potentially Biclonal Chronic Lymphocytic Leukemia Patients
- COMPLETE HEMATOLOGIC REMISSION BUT NOT MOLECULAR REMISSION IS ASSOCIATED WITH PROLONGED SURVIVAL IN PATIENTS WITH ACUTE LEUKEMIA BEFORE HEMATOPOIETIC STEM CELL TRANSPLANTATION
- Constitutive Activation of STAT1 and STAT3 Proteins on Serine and Tyrosine Residues Were Found in Majority of CLL
- CONSTITUTIVE ACTIVATION OF STAT1 AND STAT3 PROTEINS WITHOUT INTERFERON INDUCIBILITY: RELEVANCE TO THERAPY IN IGVH-UNMUTATED CLL PATIENTS
- DASATINIB EFFICACY AND TOLERANCE IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA (CML) PATIENTS RESISTANT/INTOLERANT TO IMATINIB IN THE CONTEXT OF REAL CLINICAL PRACTICE MANAGEMENT
- DEEP SEQUENCING IDENTIFIES TP53 MUTATIONS BEFORE THEIR CLONAL SELECTION BY THERAPY IN CHRONIC LYMPHOCYTIC LEUKEMIA
- Defects of ATM Gene Involving Mutation Lead to Complete Elimination of ATM Function in Chronic Lymphocytic Leukemia
- DEFINITION AND VALIDATION OF NOVEL PROGNOSTIC MARKERS IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
- Detail Characterization of 22q11 Deletion and Mir-650 Role in CLL Patients
- DETAILED MUTATIONAL ANALYSIS OF TP53 GENE REVEALS HIGH INCIDENCE OF ADDITIONAL MINOR PROPORTION MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS
- Detection and Treatment of Molecular Relapse in Acute Myeloid Leukemia with RUNX1, CBFB or MLL Gene Translocations. Frequent Quantitative Monitoring of Molecular Markers in Different Compartments and Correlation with WT1 Gene Expression.
- DETECTION OF MINIMAL RESIDUAL DISEASE IN PATIENT WITH CHRONIC LYMPHOCYTIC LEUKEMIA USING BOTH FOUR-COLOR AND EIGHT-COLOR FLOW CYTOMETRY AND QUANTITATIVE REAL TIME PCR APPROACH
- Detection of Molecular Relapse of AML by Very Frequent Quantitative Monitoring of Different Molecular Markers (Fusion Transcripts and WT1) in Different Compartments (Peripheral Blood-PB, Bone Marrow-BM, and Selected CD34+ Bone Marrow Cells) and Its..
- DETECTION OF MOLECULAR RELAPSE OF AML BY VERY FREQUENT QUANTITATIVE MONITORING OF DIFFERENT MOLECULAR MARKERS IN DIFFERENT COMPARTMENTS AND ITS TREATMENT WITH CHEMOTHERAPY OR GEMTUZUMAB OZOGAMICIN
- DO WE KNOW AN IDEAL PATIENT WITH IMMUNE THROMBOCYTOPENIA FOR RITUXIMAB TREATMENT?
- EFFICACY AND SAFETY OF IMATINIB IN THE FIRST LINE CHRONIC MYELOID LEUKEMIA (CML) TREATMENT. AN ANALYSIS OF A COMPREHENSIVE POPULATION-BASED DATABASE
- EFFICACY AND TOXICITY OF THE FLAMSA/RIC REGIMEN IN 40 PATIENTS WITH HIGH-RISK AML: A SINGLE CENTRE EXPERIENCE
- EVALUATION OF MINIMAL RESIDUAL DISEASE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA BY MULTIPARAMETRIC FLOW CYTOMETRY AND REAL-TIME PCR
- Gene-Expression Profiling of Graft-Versus-Host Disease by Oligonucleotide Microarrays
- GENOMIC COPY NUMBER ALTERATIONS IN HIGH-RISK CLL PATIENTS HARBORING TP53 DEFECTS: INSIGHTS FROM CONSECUTIVE INVESTIGATIONS
- HIGH EFFICACY OF PULSE CYCLOPHOSPHAMIDE IN CORTICOSTEROID-REFRACTORY LIVER GRAFT-VERSUS-HOST DISEASE
- High Expression of LAG3, LPL and ZAP-70 Genes in B-CLL Strongly Correlates with Unmutated IgVH and Early Therapy Requirement
- HIGH RESOLUTION CYTOGENETIC MAPPING AND WHOLE EXOME SEQUENCING REVEAL A COMPLEX PATTERN OF CHROMOSOME 6P ABERRATIONS IN PATIENTS WITH MYELOID MALIGNANCIES
- CHARACTERIZATION OF 22Q11 DELETION IN CLL PATIENTS
- CHARACTERIZATION OF P53 AND ATM ABNORMALITIES IN B-CLL PATIENTS
- CHLORAMBUCIL (CHL) AND FLUDARABINE (F) AS A NEW PRE-TRANSPLANT CONDITIONING FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): RESULTS OF IN VITRO AND IN VIVO EXPERIMENTS
- IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) – ANALYSIS OF ITS PREVALENCE, DIAGNOSTICS AND THERAPY IN THE SOUTH MORAVIAN REGION (CZECH REPUBLIC)
- IMATINIB IN THE FIRST LINE CHRONIC MYELOID LEUKEMIA (CML) TREATMENT. CAN WE COMPARE THE REAL-LIFE DATA TO CLINICAL TRIAL RESULTS?
- IMATINIB IN THE FIRST-LINE CML TREATMENT: AN ANALYSIS OF A COMPREHENSIVE NON-COMMERCIAL DATABASE OF ALL CONSECUTIVE PATIENTS IN A DEFINED POPULATION
- INCORPORATION OF NEXT-GENERATION SEQUENCING INTO ATM GENE ANALYSIS IN PATIENTS WITH CLL AND MCL
- INTRA-ARTERIAL INJECTION OF IMMUNOSUPPRESSIVE THERAPY FOR SEVERE GASTROINTESTINAL AND LIVER GVHD
- IS LEUKAPHERESIS ABLE TO IMPROVE SURVIVAL IN HYPERLEUKOCYTIC AML IF USED AS THE EARLY CYTOREDUCTION TREATMENT?
- IS NONMYELOABLATIVE TRANSPLANT SUFFICIENT TO CURE CHRONIC MYELOID LEUKEMIA?
- JAK2 Mutation and Additional Thrombophilic Markers Predispose to Thrombosis in Myeloproliferative Diseases with Thrombocythemia
- JAK2 MUTATION AND AN ADDITIONAL THROMBOPHILIC STATE ARE MAJOR PROTHROMBOTIC RISK FACTORS IN MYELOPROLIFERATIONS WITH THROMBOCYTHEMIA – DATA FROM A REGISTRY OF ANAGRELIDE-TREATED PATIENTS
- Léčba akutní myeloidní leukémie u nemocných ve věku nad 60 let. Srovnání kurativní a paliativní léčby
- LONG-TERM RESULTS OF REDUCED-INTENSITY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR 1ST CHRONIC PHASE CML
- LOW-DOSE FCR IN ELDERLY/COMORBID PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL): UPDATED RESULTS OF PROJECT Q-LITE BY CZECH CLL STUDY GROUP
- LOW-DOSE FCR IN THE TREATMENT OF ELDERLY/COMORBID PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL): UPDATED RESULTS OF PROJECT Q-LITE BY CZECH CLL STUDY GROUP
- Low-Dose FCR Is a Safe and Effective Treatment Option for Elderly/Comorbid Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Updated Results of Project Q-Lite By Czech CLL Study Group
- LOW-DOSE FLUDARABINE AND CYCLOPHOSPHAMIDE COMBINED WITH RITUXIMAB IN THE TREATMENT OF ELDERLY/COMORBID PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: PROJECT Q-LITE OF CZECH CLL STUDY GROUP
- Low-Dose Fludarabine and Cyclophosphamide Combined with Rituximab In the Treatment of Elderly/Comorbid Patients with chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Preliminary Results of Project Q-Lite by Czech CLL Study Group
- Microrna-34a As a Marker for Fludarabine Resistance and Impairment of p53-Pathway in Chronic Lymphocytic Leukemia
- MISSENSE MUTATIONS LOCATED IN STRUCTURAL P53 DNA-BINDING MOTIFS ARE ASSOCIATED WITH EXTREMELY POOR SURVIVAL IN CHRONIC LYMPHOCYTIC LEUKEMIA
- Model klinického registru umožňujícího hodnocení léčebné péče: projekt ALERT (Akutní LEukémie – klinický RegisTr)
- MOLECULAR ANALYSIS OF IGVH GENE MUTATIONAL STATUS AS A PROGNOSTIC FACTOR IN B – CLL WITHIN CZECH PATIENTS
- Molekulárně-biologické přístupy mutační analýzy genu TP53 u onkologických pacientů.
- MONITORING OF THE STATUS OF BOTH P53 ALLELES IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA - RELEVANCE TO PROGNOSIS AND TREATMENT
- MORBIDITY AND MORTALITY WITH NONMYELOABLATIVE COMPARED TO MYELOABLATIVE CONDITIONING BEFORE RELATED STEM CELL TRANSPLANTATION
- MRD LEVEL ANALYSIS IN ADULT ALL PATIENTS. ANALYSIS OF THE CZECH LEUKEMIA STUDY GROUP–FOR LIFE (CELL)
- MUTATION STATUS OF ATM GENE IN CLL PATIENTS HARBORING DELETION 11Q OR TP53 DEFECT
- Mutational Analysis of Mir-29 Family Members in Chronic Lymphocytic Leukemia
- Mutational Analysis of TP53 Gene in Chronic Lymphocytic Leukemia: Comparison of Different Methodological Approaches
- MUTATIONS IN THE TP53 GENE SHOW FEATURES OF SOMATIC HYPERMUTATION PROCESS WITH PROMINENT DIFFERENCE BETWEEN IGHV MUTATED AND UNMUTATED CHRONIC LYMPHOCYTIC LEUKEMIA
- New Characteristics of Liver Gvhd: Kinetics, and the Serum Levels of Enzymes Linked to Cholestasis
- NEW PROGNOSTIC MARKERS OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IN THE EVERYDAY HEMATOLOGICAL PRACTICE. A MULTICENTER ANALYSIS
- NOD/SCID GAMMA XENOGRAFT MODEL OF B-CELL MALIGNANCIES USING TP53- AND/OR ATM-DEFICIENT CELL LINES
- NOD/SCID IL2RGAMMA(-/-) XENOGRAFT MODEL FOR CHRONIC LYMPHOCYTIC LEUKEMIA
- Ofatumumab Added To Dexamethasone In Patients With Relapsed Or Refractory Chronic Lymphocytic Leukemia. Results From a Phase II Study Of The Czech Leukemia Study Group For Life
- P53 Inactivation and Genomic Aberrations in Relation to Imatinib Resistance in Chronic Myeloid Leukemia
- p53 Inactivation in CLL: Pattern of 110 TP53 Mutations
- PHILADELPHIA-POSITIVE ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: REAL LIFE OF TWO GEOGRAPHICAL REGIONS
- PRESENCE OF HETEROZYGOUS ATM DELETION MAY NOT BE CRITICAL FOR THE RESPONSE OF CLL CELLS TO FLUDARABINE
- PROGNOSIS OF RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AFTER COMBINED FLUDARABINE, CYCLOPHOSPHAMIDE AND RITUXIMAB (FCR) TREATMENT
- Prognostic Impact of NOTCH1 Hotspot Mutation in TP53-Mutated Patients with Chronic Lymphocytic Leukemia
- PROGNOSTIC SIGNIFICANCE OF GENETIC ABERRATIONS IN SECONDARY ACUTE MYELOID LEUKEMIA
- PROGNOSTICKÝ VÝZNAM HOT SPOT MUTACE GENU NOTCH1 U PACIENTŮ S CHRONICKOU LYMFOCYTÁRNÍ LEUKEMIÍ A SOUVISLOST S MOLEKULÁRNĚ BIOLOGICKÝMI MARKERY ONEMOCNĚNÍ
- Prognostický význam mutačního stavu genu TP53 u pacientů s B-buněčnou chronickou lymfocytární leukémií – význam monitorováni obou alel.
- Přítomnost heterozygotní delece ATM nedeterminuje odpověď CLL buněk na fludarabin
- QUALITY OF LIFE (QOL) IN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA (CML) ON IMATINIB. A PILOT STUDY.
- QUANTITATIVE DETECTION OF MINIMAL RESIDUAL DISEASE IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA USING LNA-MODIFIED TAQ-MAN PROBES AND IGH-RQ PCR
- REARRANGEMENT OF LAMBDA IMMUNOGLOBULIN LIGHT CHAIN IN CLL IS COUPLED WITH MIRNA-650 EXPRESSION
- RELATIONSHIP BETWEEN THERAPY AND CLONAL EVOLUTION OF TP53 ABNORMALITIES IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
- RESPONSE OF SECONDARY CHRONIC MYELOID LEUKEMIA TO IMATINIB. COOPERATIVE STUDY OF CML REGISTRIES CAMELIA AND INFINITY
- RITUXIMAB IN COMBINATION WITH HIGH-DOSE DEXAMETHASONE: AN EFFECTIVE TREATMENT OPTION FOR PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
- Rituximab In Combination with High-Dose Dexamethasone: An Effective Treatment Option for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia
- Rituximab Sensitizes B-CLL Cells with Inactivated p53 to Fludarabine.
- RITUXIMAB SENSITIZES SOME B-CLL SAMPLES TO FLUDARABINE AND CHLORAMBUCIL IN VITRO, REGARDLESS OF P53/ATM STATUS
- Role of p53 Gene Mutation Type in B-CLL Prognosis
- Sequence Variations in miRNA Genes Are Common and May Affect Their Expression in Patients with Chronic Lymphocytic Leukemia
- SF3B1 Mutations Frequently Occur With Both ATM Mutations and TP53 Mutations In CLL Patients
- Single Cell Analysis of IG Genes in CLL: Cases with Multiple IGH Rearrangements Are Constituted of Several Independent Clones Even When Indistinguishable By Flow Cytometry
- Single Cell Analysis Proves the Coexistence of NOTCH1 and TP53 Mutations within the Same Cancer Cells in Patients with Chronic Lymphocytic Leukemia
- Sledování exprese vybraných genů u pacientů s B-buněčnou chronickou lymfocytární leukémií – záchyt změny leukemického klonu vlivem terapie
- SROVNÁNÍ NEJČASTĚJI VYUŽÍVANÝCH METOD DETEKCE HOT SPOT MUTACE GENU NOTCH1 U PACIENTŮ S CHRONICKOU LYMFOCYTÁRNÍ LEUKEMIÍ
- Status of Minimal Residual Disease Determines Outcome of Autologous HSCT in Adults with High-Risk Acute Lymphoblastic Leukemia
- STUDIUM KLONÁLNÍ KOMPOZICE CHRONICKÉ LYMFOCYTÁRNÍ LEUKEMIE S VÍCEČETNÝMI IMUNOGLOBULINOVÝMI PŘESTAVBAMI NA ÚROVNI JEDNOTLIVÝCH BUNĚK
- STUDIUM SELEKCE NEPŘÍZNIVÝCH GENOMICKÝCH ABNORMALIT V RELAPSU CHRONICKÉ LYMFOCYTÁRNÍ LEUKEMIE
- T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN DAILY HEMATOLOGICAL PRACTICE
- T315I MUTATIONS ARE CLUSTERED WITH ADVANCED PHASES CONTRARY TO OTHER ABERRATIONS IN CML PATIENTS RESISTANT TO TKI THERAPY
- TARGETED ARRAYCGH USED FOR DETERMINING MINIMALLY DELETED REGION ON CHROMOSOME 6Q IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS
- Terapeutické monoklonální protilátky senzitivizují in vitro některé B-CLL vzorky s aberacemi genu TP53 k fludarabinu a chlorambucilu.
- THE EXPRESSION OF A SINGLE MICRORNA - MIR-34A – IS A RELIABLE MARKER FOR IMPAIRMENT OF P53-PATHWAY IN CHRONIC LYMPHOCYTIC LEUKEMIA
- THE IMPACT OF SPECIFIC MUTATIONS IN TP53 GENE ON THE RESULTS OF ALEMTUZUMAB THERAPY IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS
- The Regulation, Targets and Clinical Relevance of Microrna Mir-650 in Chronic Lymphocytic Leukemia (CLL)
- TP53 MUTATIONS BUT NOT ATM MUTATIONS ASSOCIATE WITH HIGHER IN VITRO RESISTANCE OF CLL CELLS TO RITUXIMAB
- TRANSLOCATION IS A FREQUENT MECHANISM FOR 17P DELETION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
- TREATMENT OF PHILADELPHIA-POSITIVE ADULT ACUTE LYMPHOBLASTIC LEUKEMIA IN REAL LIFE: EXPERIENCE OF ONE CENTRE
- TUMOR DYNAMICS OF CHRONIC LYMPHOCYTIC LEUKEMIA CASES WITH MULTIPLE PRODUCTIVE IGHV-IGHD-IGHJ REARRANGEMENTS
- UPREGULATED COBLL1 IN CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) PATIENTS WITH UNMUTATED IGHV IDENTIFIES A COHORT WITH INFERIOR PROGNOSIS
- USEFULNESS OF THE VORICONAZOLE PLASMA LEVELS MONITORING IN HEMATOONCOLOGICAL PTS TREATED BY ORAL FORM OF THE VORICONAZOLE
- VYHLEDÁVÁNÍ A SLEDOVÁNÍ KLONŮ S MUTACÍ TP53 V CHRONICKÉ FÁZI MYELOPROLIFERATIVNÍCH NEOPLAZIÍ (MPN)
- WHAT CAN WE CURRENTLY LEARN FROM NEW PROGNOSTIC MARKERS OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IN THE EVERYDAY HAEMATOLOGICAL PRACTICE?
- WHAT DO WE KNOW ABOUT THE REAL INCIDENCE OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND WHERE AND HOW ARE THE PATIENTS WITH CLL TREATED?
Články v Klinické onkologii
- Autologní transplantace s podáním interleukinem 2 aktivovaného štěpu periferních kmenových buněk nemocným s chronickou myeloidní leukemií
- Biologie dendritických buněk ajejich příprava pro klinické užití (přehled a předběžné výsledky)
- Cefoperazon plus sulbaktam v léčbě febrilní neutropenie a infekcí u onkologických pacientů
- Cytogenetické vyšetření lymfocytů periferní krve po stimulaci IL-2 a CpG oligonukleotidem DSP30 u pacientů s chronickou lymfocytární leukemií
- Editorial
- Filgrastim a akutní myeloidní leukemie
- Genetická diagnostika familiárních onemocnění krvetvorby
- Chlorhexidin v profylaxi a léčbě ústních komplikací protinádorové chemoterapie
- Imunomagnetická separace myelomových buněk
- Indukční léčba nemocných s akutní myeloidní leukémií protokolem ICE
- Inhibice signalizace B buněčným receptorem: první cílená léčba u chronické lymfocytární leukemie a dalších B buněčných lymfomů
- Léčba dospělých pacientů s akutní lymfoblastovou leukemií v České republice v letech 2007–2020
- Léčba relabující/refrakterní akutní lymfoblastické leukemie dnes a zítra
- Léčba retroperitoneální fibrózy rituximabem, cyklofosfamidem a dexametazonem.
- Monoklonální gamapatie klinického významu s osteosklerotickými ložisky – popis případu a přehled literatury
- Možnosti průtokové cytometrie v diagnostice postižení kostní dřeně u pacientů s nehodgkinskými lymfomy
- Nefrotoxicita konvenčního Amfotericinu B u onkologicky nemocných a možnosti její profylaxe
- Perspektivy imunoterapie v léčbě mnohočetného myelomu
- Relaps mnohočetného myelomu - jaké léčebné možnosti máme?
- Využití rituximabu v léčbě chronické lymfatické leukemie
- Význam minimální zbytkové nemoci u chronické lymfocytární leukemie
- Záchranné a periferní kmenové buňky mobílizující chemoterapie založená na kombinaci ifosfamidu a etoposidu u nemocných lymfomem se špatnou prognózou
Stránky na Linkosu
- Esenciální (primární) trombocytémie
- Historie transplantací
- Komplikace transplantací a její pozdní následky
- Leukemie
- Myeloproliferativní onemocnění
- Pravá polycytémie
- Primární myelofibróza stručně
- Příprava a postup při transplantaci
- Transplantace krvetvorných buněk
- Typy, dárci a indikace k transplantacím
